Selected research
Industry Research
Continuous Glucose Monitor (CGM) Solution Industry Research Report 2026
Market perspective
The global Continuous Glucose Monitor (CGM) Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Continuous Glucose Monitor (CGM) Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Continuous Glucose Monitor (CGM) Solution market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Continuous Glucose Monitor (CGM) Solution market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Continuous Glucose Monitor (CGM) Solution include Roche, Nutrisense, Levels Health, Eversense, Abbott, Dexcom, Medtronic, Changsha Sinocare and Beijing Yicheng Bioelectronics Technology, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Continuous Glucose Monitor (CGM) Solution market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Continuous Glucose Monitor (CGM) Solution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Continuous Glucose Monitor (CGM) Solution Market by Company
Roche
Nutrisense
Levels Health
Eversense
Abbott
Dexcom
Medtronic
Changsha Sinocare
Beijing Yicheng Bioelectronics Technology
Ottai Technology (Wuxi)
Hangzhou MicroTech Medical
Continuous Glucose Monitor (CGM) Solution Segment by Type
Hardware
Software
Continuous Glucose Monitor (CGM) Solution Segment by Application
Clinical Treatment
Sports & Fitness
Others
Continuous Glucose Monitor (CGM) Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Continuous Glucose Monitor (CGM) Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Continuous Glucose Monitor (CGM) Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Continuous Glucose Monitor (CGM) Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Continuous Glucose Monitor (CGM) Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hardware
- Software
Applications
- Clinical Treatment
- Sports & Fitness
- Others
Companies covered
- Roche
- Nutrisense
- Levels Health
- Eversense
- Abbott
- Dexcom
- Medtronic
- Changsha Sinocare
- Beijing Yicheng Bioelectronics Technology
- Ottai Technology (Wuxi)
- Hangzhou MicroTech Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Continuous Glucose Monitor (CGM) Solution by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Hardware
- 2.2.3 Software
- 2.3 Continuous Glucose Monitor (CGM) Solution by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Treatment
- 2.3.3 Sports & Fitness
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Continuous Glucose Monitor (CGM) Solution Breakdown Data by Type
- 3.1 Global Continuous Glucose Monitor (CGM) Solution Historic Market Size by Type (2021-2026)
- 3.2 Global Continuous Glucose Monitor (CGM) Solution Forecasted Market Size by Type (2027-2032)
4 Continuous Glucose Monitor (CGM) Solution Breakdown Data by Application
- 4.1 Global Continuous Glucose Monitor (CGM) Solution Historic Market Size by Application (2021-2026)
- 4.2 Global Continuous Glucose Monitor (CGM) Solution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Continuous Glucose Monitor (CGM) Solution Market Perspective (2021-2032)
- 5.2 Global Continuous Glucose Monitor (CGM) Solution Growth Trends by Region
- 5.2.1 Global Continuous Glucose Monitor (CGM) Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Continuous Glucose Monitor (CGM) Solution Historic Market Size by Region (2021-2026)
- 5.2.3 Continuous Glucose Monitor (CGM) Solution Forecasted Market Size by Region (2027-2032)
- 5.3 Continuous Glucose Monitor (CGM) Solution Market Dynamics
- 5.3.1 Continuous Glucose Monitor (CGM) Solution Industry Trends
- 5.3.2 Continuous Glucose Monitor (CGM) Solution Market Drivers
- 5.3.3 Continuous Glucose Monitor (CGM) Solution Market Challenges
- 5.3.4 Continuous Glucose Monitor (CGM) Solution Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Continuous Glucose Monitor (CGM) Solution Players by Revenue
- 6.1.1 Global Top Continuous Glucose Monitor (CGM) Solution Players by Revenue (2021-2026)
- 6.1.2 Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Players (2021-2026)
- 6.2 Global Continuous Glucose Monitor (CGM) Solution Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Continuous Glucose Monitor (CGM) Solution Head Office and Area Served
- 6.4 Global Continuous Glucose Monitor (CGM) Solution Players, Product Type & Application
- 6.5 Global Continuous Glucose Monitor (CGM) Solution Manufacturers Established Date
- 6.6 Global Continuous Glucose Monitor (CGM) Solution Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
- 7.2 North America Continuous Glucose Monitor (CGM) Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 7.4 North America Continuous Glucose Monitor (CGM) Solution Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
- 8.2 Europe Continuous Glucose Monitor (CGM) Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 8.4 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
- 9.2 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
- 10.2 South America Continuous Glucose Monitor (CGM) Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 10.4 South America Continuous Glucose Monitor (CGM) Solution Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
- 11.2 Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche
- 12.1.1 Roche Company Information
- 12.1.2 Roche Business Overview
- 12.1.3 Roche Revenue in Continuous Glucose Monitor (CGM) Solution Business (2021-2026)
- 12.1.4 Roche Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 12.1.5 Roche Recent Developments
- 12.2 Nutrisense
- 12.2.1 Nutrisense Company Information
- 12.2.2 Nutrisense Business Overview
- 12.2.3 Nutrisense Revenue in Continuous Glucose Monitor (CGM) Solution Business (2021-2026)
- 12.2.4 Nutrisense Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 12.2.5 Nutrisense Recent Developments
- 12.3 Levels Health
- 12.3.1 Levels Health Company Information
- 12.3.2 Levels Health Business Overview
- 12.3.3 Levels Health Revenue in Continuous Glucose Monitor (CGM) Solution Business (2021-2026)
- 12.3.4 Levels Health Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 12.3.5 Levels Health Recent Developments
- 12.4 Eversense
- 12.4.1 Eversense Company Information
- 12.4.2 Eversense Business Overview
- 12.4.3 Eversense Revenue in Continuous Glucose Monitor (CGM) Solution Business (2021-2026)
- 12.4.4 Eversense Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 12.4.5 Eversense Recent Developments
- 12.5 Abbott
- 12.5.1 Abbott Company Information
- 12.5.2 Abbott Business Overview
- 12.5.3 Abbott Revenue in Continuous Glucose Monitor (CGM) Solution Business (2021-2026)
- 12.5.4 Abbott Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 12.5.5 Abbott Recent Developments
- 12.6 Dexcom
- 12.6.1 Dexcom Company Information
- 12.6.2 Dexcom Business Overview
- 12.6.3 Dexcom Revenue in Continuous Glucose Monitor (CGM) Solution Business (2021-2026)
- 12.6.4 Dexcom Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 12.6.5 Dexcom Recent Developments
- 12.7 Medtronic
- 12.7.1 Medtronic Company Information
- 12.7.2 Medtronic Business Overview
- 12.7.3 Medtronic Revenue in Continuous Glucose Monitor (CGM) Solution Business (2021-2026)
- 12.7.4 Medtronic Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 12.7.5 Medtronic Recent Developments
- 12.8 Changsha Sinocare
- 12.8.1 Changsha Sinocare Company Information
- 12.8.2 Changsha Sinocare Business Overview
- 12.8.3 Changsha Sinocare Revenue in Continuous Glucose Monitor (CGM) Solution Business (2021-2026)
- 12.8.4 Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 12.8.5 Changsha Sinocare Recent Developments
- 12.9 Beijing Yicheng Bioelectronics Technology
- 12.9.1 Beijing Yicheng Bioelectronics Technology Company Information
- 12.9.2 Beijing Yicheng Bioelectronics Technology Business Overview
- 12.9.3 Beijing Yicheng Bioelectronics Technology Revenue in Continuous Glucose Monitor (CGM) Solution Business (2021-2026)
- 12.9.4 Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 12.9.5 Beijing Yicheng Bioelectronics Technology Recent Developments
- 12.10 Ottai Technology (Wuxi)
- 12.10.1 Ottai Technology (Wuxi) Company Information
- 12.10.2 Ottai Technology (Wuxi) Business Overview
- 12.10.3 Ottai Technology (Wuxi) Revenue in Continuous Glucose Monitor (CGM) Solution Business (2021-2026)
- 12.10.4 Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 12.10.5 Ottai Technology (Wuxi) Recent Developments
- 12.11 Hangzhou MicroTech Medical
- 12.11.1 Hangzhou MicroTech Medical Company Information
- 12.11.2 Hangzhou MicroTech Medical Business Overview
- 12.11.3 Hangzhou MicroTech Medical Revenue in Continuous Glucose Monitor (CGM) Solution Business (2021-2026)
- 12.11.4 Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 12.11.5 Hangzhou MicroTech Medical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst